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Background: Aging is associated with thymus involution leading to a reduction in naive T cells
and to an accumulation of effector-memory cells. Apoptosis is a key mechanism to clear the
immune system from activated and harmful cells. In asthma the stimulation of T cells by envi-
ronmental antigens can decrease naive cells and sustain activated cells. The aim of this work
was to evaluate the imbalance between CD45RA and CD29 cells during the aging process and
their changes in elderly asthma and to evaluate how elderly and chronic diseases like asthma
can affect susceptibility to apoptosis.
Methods: Elderly and young adult healthy volunteers and elderly asthmatic patients were sub-
mitted to skin prick tests, immunoglobulin determination and ﬂow cytometry analyses of CD3,
CD4, CD8, CD45RA, CD29, and CD95.
Results: Serum IgE was increased in allergic patients (p = 0.0001). Asthmatics presented an
increase in CD4 cells (p < 0.05). CD45RA was signiﬁcantly decreased in elderly individuals
(p < 0.05) and this decrease was higher in asthmatics (p < 0.05). CD29 was increased in elderly
healthy individuals compared to the control young group (p = 0.0001). A negative correlation
between CD29 and CD45RA (p < 0.05) was observed. CD95 lymphocytes increased in elderly
(p = 0.0001) and a positive correlation between age and CD95 (p < 0.05) was found. Asthmatic
patients showed signiﬁcant decreases in CD95 (p = 0. 0001).Please cite this article in press as: Todo-Bom A, et al. Aging
subsets. Allergol Immunopathol (Madr). 2011. doi:10.1016/j.al
Conclusions: Naive cells are key cells in the defence against infections and their decrease in
the elderly and in asthma is a bad prognosis factor. The reduction of apoptosis markers can
promote the persistence of acti
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Table 1 Gender and age distribution in control and asth-
matic groups
Population n Gender (M/F) Mean age Range














































































The following were considered exclusion criteria: smok-Control young 33 8/25 30.2 ± 11.3 22/38
Asthmatics 95 32/63 72.4 ± 5.1 65/87
nd although this procedure suffers a reduction during
he growth process it can persist during adulthood.1,2
ntigen exposure determines the expression of new sur-
ace molecules and confers proliferative properties to
ells transforming them into effector and memory cells.
epeated stimulation with identical antigenic proteins elic-
ts responses of cross-reactivity increasing the survival of
emory T lymphocytes (TL) and the expansion of these cell
ines, while limiting the expansion of naive cell lines.3
The most profound age related changes described within
cell populations are the decrease in the number of naive
ells and the accumulation of sensitised cells. Moreover,
further decrease of this lymphocyte population can be
bserved when the exposure to new pathogens induces the
eplacement of old memories for new ones.3 The decrease
f naive T lymphocytes contributes to the impoverish-
ent of lymphocyte repertoires with defective responses to
ew antigens.4,5 However, a substantial naive T-cell pool is
aintained even in centenarian individuals and some data
uggest that their relative and absolute values may remain
irtually unchanged after 40 years of life. Extrathymic dif-
erentiation of TL can become prevalent in the elderly.6
mmunohistological studies showed a reduction in the num-
er of CD45RA naive lymphocytes in lymph nodes associated
o aging.7
The CD29 is the 1 subunit of the integrin family from
dhesion receptors that is expressed when a cell enters the
1 phase of the cell cycle. This molecule is often present in
emory cells and tends to increase in the elderly.8,9
Apoptosis is a key mechanism in the elimination of acti-
ated cells that expand in excess during the course of a
hysiological immune response. The Fas death receptor (also
amed CD95 or APO-1) is an integral part of the physiological
egulation of apoptosis. In aging, the process of apoptosis
stablishes the preferential elimination of memory senes-
ent cells and its deregulation is associated to disease.10,11
Several environmental factors and health conditions have
recognised capacity for eliciting cell activation into mem-Please cite this article in press as: Todo-Bom A, et al. Aging
subsets. Allergol Immunopathol (Madr). 2011. doi:10.1016/j.al
ry and effectors populations and to trigger apoptosis with
arying impact on successful aging.12
In allergic asthma there is a continuous stimulation of





Table 2 Average percentage of predicted spirometric values in a
n Fev1 (%)
Severe asthma 19 51.8± 10.0
Mild asthma 76 87.6± 17.8
Predicted values were measured according to Knudson et al.14
Fev1: forced expiratory volume in 1 s; Fev1BD: FEV1 after bronchodilat PRESS
A. Todo-Bom et al.
aive T cells. A decrease in apoptosis can also help to sustain
he airway inﬂammation that characterises the disease.
The aim of this work was to evaluate the imbalance
etween CD45 and CD29 cells during the aging process and
o analyse the changes in these cell phenotypes in elderly
sthma patients. A second goal was to compare suscep-
ibility to apoptosis and how it affects aging and chronic
espiratory diseases such as asthma.
ethods
opulation
group of 58 elderly healthy volunteers older than 65 years
f age (mean age 79.2± 7.1); a group of 33 healthy young
dults (mean age 30.2+11.3 years); and a group of 95 individ-
als with controlled asthma also older than 65 years of age
mean age 72.4± 5.1 years) attending a chest disease outpa-
ient department were studied. All the patients had a history
f intermittent chest tightness, wheezing or shortness of
reath for at least 30 years prior to study participation con-
istent with the diagnosis of asthma according to the Global
nitiative for Asthma.13 All the patients were using 250g to
00g of beclometasone dipropionate in mild to moderate
sthma or 250g of ﬂuticasone propionate daily associated
ith long-acting ß2-agonists in severe asthma and short-
cting ß2-agonists as needed. Other anti-asthmatic drugs
ere withdrawn at least four weeks prior to the study.
ll patients were examined by a physician and underwent
pirometric testing using the same equipment (Vitalograph
ompact) at least six hours after the last dose of any bron-
hodilator. Predicted values were measured according to
nudson et al.14 Subjects’ spirometric performances were
ssessed by means of a computerised program following the
merican Thoracic Society (ATS) 94 criteria. Approval for
nalysis was determined using the ATS 94 criteria, and accu-
acy was achieved if, within the same evaluation, three
urves were acceptable and reproducible. Patients with
evere asthma had FEV1 percentage values in spirometry
ower than 60% of the predicted (Tables 1, 2).
All the studied individuals were able to perform their
wn daily tasks, carrying out regular physical activity. None
f them had had any respiratory infections in the previous
onth to their inclusion in the study. No other clinically
elevant diseases were reported.and asthma—–Changes in CD45RA, CD29 and CD95 T cells
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ng, cancer, autoimmune disease, infection, diabetes, heart
ailure, renal failure, chronic hepatic disease, and recent
xposure to environmental risk factors for pulmonary dis-
ases.
sthmatics
Fev1% BD VC% Tiffeneau
10.2± 3.7 68.1± 10.2 70.1± 9.7
12.4± 6.2 94.5± 15.5 83.5± 13.0
ation; VC: vital capacity.
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Table 3 Serum Igs values in asthmatics
IgG IgA IgM IgE
Allergic asthma 11.6± 2.7 3.2± 2.1 1.2± 1.4 362± 310/a
Non allergic asthma 10.8± 2.3/ns 3.1± 2.2/ns 1.3± 0.7/ns 92± 193
independent samples. Variables that were not distributed
normally were evaluated using the Mann-Whitney non-
parametric test. P-values less than 0.05 were considered
signiﬁcant. Statistical comparisons were made between
elderly healthy volunteers and healthy young adults and
between elderly asthmatics and healthy elderly individu-
als. Differences between allergic and non-allergic asthmatic
patients were also analysed.
Results
Sixty-ﬁve asthmatic patients had positive tests to at least
one allergen. The control population and the remaining asth-
matics had negative skin prick tests.
Serum immunoglobulin (Ig) IgG, IgA and IgE were higher
and IgM lower in allergic patients when compared to non-
allergic patients (Table 3).
The percentual values of CD3,CD4 and CD8 blood lym-
phocytes were within normal ranges. CD3 lymphocyte
percentage in asthmatic patients was similar to the control
groups and CD3+CD8+ lymphocytes were slightly decreased
without statistical signiﬁcance in asthmatic patients com-
pared to control group of the same age. Only CD3+CD4+ cells
were signiﬁcantly increased in asthmatic patients (Table 4).
The mean percentage of naive CD45RA and CD4+ CD45RA
+ decreased signiﬁcantly in the elderly individuals studied.
The mean percentage of naive CD45RA was also signiﬁcantly
deceased in asthmatic patients when compared to the con-
trol group of the same age. CD4+ CD45RA + and CD8+CD45RA
+ cells were slightly reduced in asthmatics (Table 5).
The mean percentage of CD4+CD29+ and CD8+CD29+ lym-
phocytes in the elderly was signiﬁcantly increased both in
asthmatics and healthy individuals. The CD8+CD29+ per-
centage in the asthmatic patient group was above the
percentage found in the young control group but was sig-
niﬁcantly decreased when compared to the elderly control
group (Table 5).
The mean percentage of CD95 lymphocytes in elderly
health individuals was signiﬁcantly increased when
Table 4 Percentual values of lymphocytes populations in
asthmatics and control groups
Control Young Control Elderly AsthmaIgG, IgM and IgA are expressed in mg/l; IgE is expressed in IU.
a Statistical signiﬁcance p = 0.0001; ns: no signiﬁcance.
Approval to this study was received from institutional
review board of the Coimbra University Hospital, and all
individuals were selected after informed consent.
Methods
Skin prick tests to 20 common aeroallergens were
performed to all individuals involved in the study
(ALKABELLO/Lancetter-tames Hollister Stier). Subjects
were classiﬁed as allergic with one positive test associated
with clinical symptoms. The remaining asthmatics were clas-
siﬁed as non-allergic.
Immunoglobulin G (IgG), IgA and IgM were measured in
total serum by nephelometry and total serum IgE was mea-
sured using a commercial kit (Coat-A-Count® Total IgE IRMA,
DPC®, CA, USA) based on an Immuno-radiometric assay
(IRMA) of solid phase. This kit uses monoclonal antibodies
anti-IgE with I125-labelled in the liquid phase and polyclonal
antibodies anti-IgE attached to the wall of the polystyrene
tube.
Therefore, the IgE present in the sample was retained
between these two antibodies. These tubes were mea-
sured using a gamma counter (Gamma-C-12, DPC®, CA,
USA) for one minute. Total IgE concentration in the sam-
ple was directly proportional to the counts per minute. This
concentration was determined by comparison with provided
calibrators. The kit sensitivity was 0.5 IU/ml.
The study of peripheral blood (PB) lymphocytes was
performed using ﬂow cytometry assay. 100ul of PB was
incubated with monoclonal antibodies for 10minutes at
room temperature in the dark. To determine the main
populations, a single tube with Lymphogram (Cytognos,
Salamanca, Spain) containing monoclonal antibodies anti-
CD4 stained with phycoerythrin cyanin 5 (PECy5), CD8 with
ﬂuorescein-isothiocyanate (FITC), CD3 with phycoerythrin
(PE) was used. Moreover we evaluated CD45RA, CD29 and
CD95 (Immunotech, Marseille, France) stained with FITC,
CD8 (Dako, Denmark) with PE, CD3 and CD4 with PECy5
(Dako, Denmark), according to manufacturers’ speciﬁca-
tions.
Flow Cytometry (FACS) data were collected on a FACS
Calibur (BD Biosciences, San Jose, CA, USA) using the
Cellquest® acquisition software and analysed by Paint-a-
gate® software.
Statistical analysisPlease cite this article in press as: Todo-Bom A, et al. Aging and asthma—–Changes in CD45RA, CD29 and CD95 T cells
subsets. Allergol Immunopathol (Madr). 2011. doi:10.1016/j.aller.2011.01.002
Statistical analysis was performed using SPSS 12.0 software
package. The Kolmogorov —Smirnov test was used to check
if variables were normally distributed. For those with a nor-
mal distribution the parametric t test was used for two
CD3 75.0 ± 3.1 73.6 ± 9.9/ns 73.4 ± 7.6/ns
CD3+CD4+ 43.2 ± 5.1 41.8 ± 10.4/ns 45.4 ± 9.6/a
CD3+CD8+ 22.2 ± 4.3 25.0 ± 9.5/ns 22.9 ± 8.0/ns
a Statistical signiﬁcance p < 0.05; ns: no signiﬁcance.
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Table 5 Percentual values of lymphocytes populations in non-allergic asthmatics, allergic asthmatics and control groups.
Control Young Elderly Control Allergic asthma Non-allergic asthma
CD45RA 64.3 ± 7.2 59.6 ± 9.8/a 55.3 ± 9.6/a 54.0 ± 10.4/a
CD45RA+CD4+ 22.4 ± 6.4 16.2 ± 9.6/a 16.2 ± 10.0/ns 14.8 ± 5.0/ns
CD45RA+CD8+ 21.5 ± 4.1 22.8 ± 8.0/ns 20.4 ± 6.9/ns 20.0 ± 7.0/ns
CD29+CD4+ 20.1 ± 2.1* 29.7 ± 7.5/a 27.4 ± 7.2/ns 28.7 ± 7.0/ns






















































































aCD95 13.8 ± 10.8* 52.6 ± 1
a Statistical signiﬁcance p = 0.0001. ns = no signiﬁcance.
* Only done in 20 individuals (mean age 37.8± 12.2 years).
ompared to the young control group. Conversely, the
D95 lymphocytes in the asthmatic patients group was
igniﬁcantly decreased when compared to the elderly
ontrol group although the values found were still higher
han those of the younger healthy individuals (Table 5).
iscussion and conclusions
lthough the skin reactivity and IgE values tend to decrease
ith age, elderly asthmatics have higher sensitisation to
nvironmental allergens than the general population of the
ame age group. The asthmatics studied had intense cuta-
eous reactivity to aeroallergens, a Th2 immune response
onserved and high levels of total serum IgE when com-
ared to the control group (p = . 0001)15—17 The asthmatics
lso presented a signiﬁcant increase of CD3+CD4+ lympho-
ytes compared to the control group (p < 0.05), which can be
ssociated to preserved humoral response despite the long
isease evolution of the patients studied.
A crucial problem of the immune system in the elderly
s the reduced proliferative cell capacity and the delay
f clonal expansion in response to antigenic exposure as
result of stem cell decrease. The production of speciﬁc
ntibodies in response to vaccines and to environmental
ntigens is reduced in elderly but the production of autoan-
ibodies is increased and the total serum immunoglobulin
evels remain unchanged.18 A selective decline in IL2 and
FN  is observed while IL4 and IL6 production is kept within
ormal values. This adjustment in the cytokines balance is
ccomplished by a normal or increased humoral response
nd a decrease in cellular response.19 The CD45 family (com-
on leukocyte antigen) consists of multiple isoforms, which
iffer only in length and glycosylation of their extracellu-
ar domains. The different distribution of these isoforms in
eukocytes and in particular on T cells plays a crucial role
n cell activation and pathways signalling mediated by this
eceptor. The expression of different isoforms of CD45R is
hus regulated during the maturation and activation of T
ells. T cells with a naive phenotype express CD45RA dif-
erentiation markers and diminish throughout life, which
s associated with a gradual onset of memory phenotypes.
hen asthmatics are exposed to allergen stimulation only
D45R0 cells can express activation markers.20,21Please cite this article in press as: Todo-Bom A, et al. Aging
subsets. Allergol Immunopathol (Madr). 2011. doi:10.1016/j.al
This study showed a signiﬁcant reduction in the expres-
ion of CD45RA in elderly health individuals when compared
ith a young control group (p < 0.05). This ﬁnding con-
rms the reported decrease of naive cells during the aging




a39.7 ± 18.6 39.5 ± 17.9
ion posed an additional risk for this reduction. In fact the
eported reduction was even more evident in elderly asth-
atics (p < 0.05). The expression of CD45RA on CD4 and
D8 was also reduced in asthma. The CD4+CD45RA+ subtype
eached 16% while the values of CD8+CD45RA+ exceeded
0%.
The CD45RA can be expressed in cells previously acti-
ated that entered in a resting state. This decreased
esponse to stimulation and lower functional activity, is
robably linked to a lack of IL2 production.22,23 In asth-
atics the existence of a continued exposure to allergenic
ources or other airborne hazardous substances is accepted,
esulting in a continuous stimulation of the immune sys-
em, mainly of the Th2 cells. This stimulation will sustain
he setting up of memory phenotypes particularly in chronic
iseases. Even in non-allergic asthmatics the bronchi inﬂam-
atory response is connected with exposure to inhalatory
riggers. This phenomenon was also described in individu-
ls with chronic infections where the offending agent was
resent as a persistent stimulus for the immune response.
n this age group a marked reduction in the ability of iden-
ifying new allergens and promoting an effective immune
esponse is observed. This reduction in acquisition of new
kills is connected to the preservation of memory pheno-
ypes acquired throughout life, which are speciﬁc to an
xtensive repertoire of antigens. It is therefore assured a
rompt and effective response to the recall antigens, while
here is a restrict response to new challenges.24,25 Naive cells
re essential in the defence against acute infections and
s so their decrease in elderly asthma, particularly in CD8
henotypes, should be regarded as a bad prognosis factor.
The CD29 receptor is a homing molecule expressed
n activated cells that potentiates T cell adhesion to
ndothelium and is involved in cellular response to speciﬁc
ntigenic challenge. The CD29 is preferentially expressed in
D4+CD45R0+ memory cells. In asthma this molecule tends
o increase following allergen stimulation, and is especially
ssociated with memory phenotypes.26 CD29 lymphocytes
ere signiﬁcantly increased both in elderly healthy indi-
iduals and elderly asthmatics. The mechanism leading to
ncreased expression in aging is probably dominant and
herefore overlaps the arise expected from asthma.3
If we analyse the elderly population, a signiﬁcant neg-
tive correlation between CD29 and CD45RA is observedand asthma—–Changes in CD45RA, CD29 and CD95 T cells
ler.2011.01.002
eaning that the presence of a higher number of cells
arked by CD45RA is associated to a smaller number of pos-
tive cells for CD29, both in asthmatics (PC = -0.25, p < 0.05)
nd in group control (PC = -0.45, p < 0.05). This observation
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strengthens the fact that the decrease of naive cells tends
to be inversely related to the expression of CD29, a marker
of activation and homing present in memory cells also in
elderly.
Apoptosis is a natural defence mechanism against dis-
abled or dead cells that are harmful to the physical integrity
of the individual. Susceptibility to apoptosis measured by
CD95 expression is reﬂected by an increase of this recep-
tor in the elderly and suggests that apoptosis is important
in the aging processes.26,27 The studied elderly healthy
individuals had a signiﬁcantly increased value of CD95 com-
pared to the control group of young adults (p = 0.0001)
and compared to asthmatic patients (p = 0.0001). A positive
correlation between age and CD95 was found (PC = 0.446,
p < 0.05). The resistance of T lymphocytes to apoptosis,
namely the reduction of expression of receptors that can
initiate this process of cell death, could act by promoting
the maintenance of activated and memory cells and their
intervention in the inﬂammatory process characteristic of
bronchial asthma.28—31 In asthma there is a higher probabil-
ity of decreased expression of apoptosis markers by blood
cells overcoming, in some cases, the growing trend associ-
ated with the aging process. Recent studies have shown an
increased incidence of cancer, particularly lung cancer, in
elderly asthmatics.32,33 The observed reduction of markers
expected to initiate processes of apoptosis can also promote
the persistence of abnormal or damaged cells and conse-
quent neoplasic condition.
The better knowledge of the immunoinﬂammatory path-
way of elderly asthmatics can provide important information
to improve the outcome of these patients.
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